Kuo-Kai Chin

7PUBLICATIONS
35CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsBiomedical instrumentation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 10, 2026
Overcoming MEN1-mediated resistance with menin inhibitor switching in KMT2A-rearranged acute myeloid leukemia.

Kuo-Kai Chin, Maher Abdul-Hay, Mihir Shukla

|Dec 06, 2025
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.

Kuo-Kai Chin, Brian J Ball, Yasmin Abaza

|Apr 08, 2025
Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.

Meira Yisraeli Salman, Alexander R Terry, Andriy Derkach

|Oct 25, 2024
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis.

Joseph Pidala, Jongphil Kim, Denise Kalos

|Oct 14, 2024
HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML.

Kuo-Kai Chin, Andriy Derkach, Christopher Famulare

|May 30, 2020
E-HeaRT BPA: electronic health record telemetry BPA.

Kuo-Kai Chin, David Svec, Benjamin Leung

Pageof 2

Frequent Collaborators

3 joint publications

Andriy Derkach

3 joint publications

Mark B Geyer

2 joint publications

Aaron D Goldberg

2 joint publications

Sheng F Cai